LP
TXG icon

LMR Partners’s 10x Genomics TXG Stock Holding History

LMR Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,887
Closed -$243K – 1649
2025
Q1 		$243K Buy
+27,887
New +$352K ﹤0.01% 1030
2024
Q4 		– Sell
-70,303
Closed -$1.59M – 1612
2024
Q3 		$1.59M Buy
+70,303
New +$1.45M 0.01% 658
2024
Q1 		– Sell
-12,969
Closed -$726K – 1317
2023
Q4 		$726K Buy
+12,969
New +$564K 0.01% 611
2022
Q3 		– Sell
-5,809
Closed -$263K – 1306
2022
Q2 		$263K Buy
+5,809
New +$301K ﹤0.01% 1026
2020
Q4 		– Sell
-22,942
Closed -$2.86M – 638
2020
Q3 		$2.86M Buy
+22,942
New +$2.41M 0.06% 127

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LMR Partners's TXG Position: Q2 2025 in Review

LMR Partners sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 27,887 shares — an estimated $243K sold.

LMR Partners first reported a position in TXG in Q3 2020 and held it in 5 quarters. The position peaked at $2.86M in Q3 2020. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • LMR Partners reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • LMR Partners sold 27,887 10x Genomics shares in Q2 2025, an estimated $243K.
  • LMR Partners first reported a position in 10x Genomics in Q3 2020 and held it in 5 quarters.
  • LMR Partners's 10x Genomics position peaked at $2.86M in Q3 2020.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.